This morning Concepta Diagnostics, maker of the take-home home fertility monitoring system myLotus, announced a deal with the Walgreens Boots Alliance to sell its product.
This news marks the first commercial agreement for the system, which was officially launched in December. So far the system has been approved for a CE mark, allowing the London-based company to begin an EU roll out.
“Boots are...